BIO vs SDGR · rev $2.58B vs rev $255.9M
BIO (BIO) versus Schrodinger Inc (SDGR) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Schrodinger Inc (SDGR) is a health information services company listed on NASDAQ.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported SDGR revenue for 2025-12-31 was $255.9M. Net income was -$103.3M. Revenue was up 23.3% from 2024-12-31 to 2025-12-31. SDGR currently screens at market cap $1.16B.
BIO currently screens at market cap $0. SDGR currently screens at market cap $1.16B.
Not investment advice. Open the BIO and SDGR stock pages for the full models.
Not investment advice.